Interview: Hemogenyx

This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator

The Hemogenyx breakthrough heralds the double whammy of the end of chemotherapy and the need for bone marrow transplants to treat blood diseases, as well as a new investment situation.

Dr. Vladislav Sandler is the founder and CEO of Hemogenyx and Adrian Beestan, Director at Hemogenyx Pharmaceuticals talk to host Zak Mir about the company’s mission.

 

[youtube https://www.youtube.com/watch?v=6kG7G_Hwo9U&w=560&h=315]
Zak Mir

Zak Mir

About Me

Zak Mir is a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator. Zak presents the daily Bulletin Board Heroes which can be seen here at Share Talk

Recent Posts

Zak Mir Twitter

RT @smallcappick: #Aquis IPO in January 2022 @ZaksTradersCafe Lift Global Ventures PLC CEO #Zak #Mir joins... Read More

Jan 15 2022, 10:30 am

RT @flv_firstlook: Genflow #GENF will make its LSE debut in Q1 of 2022 with a... Read More

Jan 15 2022, 10:07 am

RT @Jarvy55: #EUA 🚀 https://t.co/atKezbgq8j Read More

Jan 14 2022, 5:23 pm

Bulliten Board Heroes

Malcare WordPress Security